Yasutaka Tajima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasutaka Tajima has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Yasunori Mito
Department of Neurology, Sapporo City General Hospital, Japan
15 shared publicationsAkihisa Matsumoto
7 shared publicationsHiroaki Yaguchi
Department of Neurology Sapporo City General Hospital Sapporo Japan
7 shared publications- Kazumasa Sudo
Sapporo City General Hospital, Sapporo, Japan
4 shared publications Kazumasa Sudoh
3 shared publicationsAkihisa Matumoto
Department of Neurology, Sapporo City General Hospital
2 shared publications
Latest Publications
- Open Access
- 1 December 2024
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 63 (23) , 3261-3262
Temporal MRI Alterations in Methanol Intoxication
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 1 December 2024
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 63 (23) , 3261-3262
Open AccessTemporal MRI Alterations in Methanol Intoxication
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 9 November 2023
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 12 (3) , 212-213
Neuroradiologic features associated with heat stroke
- 9 November 2023
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 12 (3) , 212-213
Neuroradiologic features associated with heat stroke
- Open Access
- 20 January 2022
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 13 (2) , 124-126
Coronavirus disease 2019‐associated encephalopathy: Characteristic brainstem and bilateral temporal lobe involvement
- 20 January 2022
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 13 (2) , 124-126
Open AccessCoronavirus disease 2019‐associated encephalopathy: Characteristic brainstem and bilateral temporal lobe involvement
- 30 March 2021
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 12 (3) , 179-181
Fatal fulminant inflammation in the diaphragm resulting from pembrolizumab‐related myopathy
- 30 March 2021
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 12 (3) , 179-181
Fatal fulminant inflammation in the diaphragm resulting from pembrolizumab‐related myopathy
- Open Access
- 28 January 2021
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 13 (1) , 53-58
Very-Late-Onset Neuromyelitis Optica Spectrum Disorder in a Patient with Breast Cancer and Parkinson Disease
Anti-aquaporin-4 (anti-AQP-4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder resulting in severe, recurrent optic neuritis, transverse myelitis, brain stem syndrome, and other types of neurological involvement. Its median age of onset has been reported to be around 40 years. We report herein a case of very-late-onset NMOSD (76 years of age) and try to promote its awareness as a type of neurological deterioration in elder patients. A 76-year-old woman suffering from Parkinson disease was admitted to our hospital because of consciousness disturbance. Cranial magnetic resonance imaging revealed the presence of fluid-attenuated inversion recovery high-signal-intensity lesions in the right peri- and intralateral ventricle. Part of this lesion and the meninges showed gadolinium enhancement. Physical examination revealed the presence of a tumor in the right breast, which was later diagnosed as invasive ductal carcinoma. In addition, laboratory examinations led to the detection of anti-AQP-4 antibodies in her serum; consequently, the patient was diagnosed as having NMOSD. She received initial pulsed steroid therapy, followed by right mastectomy. Although the patient’s consciousness improved significantly, she developed abrupt-onset bilateral leg weakness and multiple longitudinal spinal cord lesions. Additional steroid therapy ameliorated the patient’s leg weakness and reduced the swelling of the spinal cord.
- 28 January 2021
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 13 (1) , 53-58
Open AccessVery-Late-Onset Neuromyelitis Optica Spectrum Disorder in a Patient with Breast Cancer and Parkinson Disease
Anti-aquaporin-4 (anti-AQP-4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder resulting in severe, recurrent optic neuritis, transverse myelitis, brain stem syndrome, and other types of neurological involvement. Its median age of onset has been reported to be around 40 years. We report herein a case of very-late-onset NMOSD (76 years of age) and try to promote its awareness as a type of neurological deterioration in elder patients. A 76-year-old woman suffering from Parkinson disease was admitted to our hospital because of consciousness disturbance. Cranial magnetic resonance imaging revealed the presence of fluid-attenuated inversion recovery high-signal-intensity lesions in the right peri- and intralateral ventricle. Part of this lesion and the meninges showed gadolinium enhancement. Physical examination revealed the presence of a tumor in the right breast, which was later diagnosed as invasive ductal carcinoma. In addition, laboratory examinations led to the detection of anti-AQP-4 antibodies in her serum; consequently, the patient was diagnosed as having NMOSD. She received initial pulsed steroid therapy, followed by right mastectomy. Although the patient’s consciousness improved significantly, she developed abrupt-onset bilateral leg weakness and multiple longitudinal spinal cord lesions. Additional steroid therapy ameliorated the patient’s leg weakness and reduced the swelling of the spinal cord.
- Open Access
- 1 May 2019
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 58 (9) , 1341-1347
Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
To explore non-motor comorbidities of myasthenia gravis (MG), we present two cases of thymomaassociated MG patients. Alopecia, pure red cell aplasia, and thymoma-associated multiorgan autoimmunity were observed in Case 1, and alopecia, thrombocytopenia, hypogammaglobulinemia and nephrotic syndrome were observed in Case 2. In both cases, autoreactive T lymphocytes inappropriately stimulated by thymus tissue may have played key roles in generating the various autoimmune-associated symptoms. Consequently, systemic immunological involvement due to the thymoma-associated breakdown of immunoregulations in both motor and non-motor systems should be considered in MG patients.
- 1 May 2019
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 58 (9) , 1341-1347
Open AccessNon-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
To explore non-motor comorbidities of myasthenia gravis (MG), we present two cases of thymomaassociated MG patients. Alopecia, pure red cell aplasia, and thymoma-associated multiorgan autoimmunity were observed in Case 1, and alopecia, thrombocytopenia, hypogammaglobulinemia and nephrotic syndrome were observed in Case 2. In both cases, autoreactive T lymphocytes inappropriately stimulated by thymus tissue may have played key roles in generating the various autoimmune-associated symptoms. Consequently, systemic immunological involvement due to the thymoma-associated breakdown of immunoregulations in both motor and non-motor systems should be considered in MG patients.
- Open Access
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (6) , 867-871
Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy
A 27-year-old woman with optic neuritis and cervical myelitis developed hypertrophic demyelinating polyneuropathy. It was hypothesized that the diagnosis was combined central and peripheral demyelination. A hypertrophic nerve was observed subcutaneously, and magnetic resonance imaging demonstrated marked hypertrophy of the nerve roots. The patient was negative for anti-aquaporin 4 antibodies. Her anti-neurofascin 155 antibody levels was slightly elevated, but it was not definitely positive. Pulsed steroid therapy and the administration of immunoglobulin ameliorated her symptoms. Molecules in both the peripheral and central nervous systems might be target antigens, but further investigations will be needed to clarify the precise pathogenic mechanisms.
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (6) , 867-871
Open AccessPossible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy
A 27-year-old woman with optic neuritis and cervical myelitis developed hypertrophic demyelinating polyneuropathy. It was hypothesized that the diagnosis was combined central and peripheral demyelination. A hypertrophic nerve was observed subcutaneously, and magnetic resonance imaging demonstrated marked hypertrophy of the nerve roots. The patient was negative for anti-aquaporin 4 antibodies. Her anti-neurofascin 155 antibody levels was slightly elevated, but it was not definitely positive. Pulsed steroid therapy and the administration of immunoglobulin ameliorated her symptoms. Molecules in both the peripheral and central nervous systems might be target antigens, but further investigations will be needed to clarify the precise pathogenic mechanisms.
- Open Access
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (6) , 873-876
Fatal Meningoencephalomyelitis due to the Tick-borne Encephalitis Virus: The First Detailed Neurological Observation in a Japanese Patient from the Central Part of Hokkaido Island
To date, the only instance of tick-borne encephalitis (TBE) in Japan was reported from the southern part of Hokkaido Island in 1993; no other cases have been reported since then. We herein report the first case of TBE reported in the central part of Hokkaido Island, and describe the fatal clinical course of a patient who presented with meningoencephalomyelitis, which partly involved the nerve root. Magnetic resonance imaging (MRI) of the patient's cranium and spine revealed characteristic central nervous system involvement. Our case report is extremely relevant to efforts to protect public health and for precautions against TBE pandemics.
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (6) , 873-876
Open AccessFatal Meningoencephalomyelitis due to the Tick-borne Encephalitis Virus: The First Detailed Neurological Observation in a Japanese Patient from the Central Part of Hokkaido Island
To date, the only instance of tick-borne encephalitis (TBE) in Japan was reported from the southern part of Hokkaido Island in 1993; no other cases have been reported since then. We herein report the first case of TBE reported in the central part of Hokkaido Island, and describe the fatal clinical course of a patient who presented with meningoencephalomyelitis, which partly involved the nerve root. Magnetic resonance imaging (MRI) of the patient's cranium and spine revealed characteristic central nervous system involvement. Our case report is extremely relevant to efforts to protect public health and for precautions against TBE pandemics.
- Open Access
- 29 September 2016
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2016, 1-4
Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation
In rare instances, recipients of organ transplants from human T-lymphotropic virus type I- (HTLV-I-) positive donors reportedly developed neurologic symptoms due to HTLV-I-associated myelopathy (HAM). We present herein two cases of HAM associated with renal transplantation from HTLV-I seropositive living-donors. The first patient was a 42-year-old woman with chronic renal failure for twelve years and seronegative for HTLV-I. She underwent renal transplantation with her HTLV-I seropositive mother as the donor, and she developed HAM three years after the transplantation. The second patient was a 65-year-old man who had been suffering from diabetic nephropathy. He was seronegative for HTLV-I and underwent renal transplantation one year previously, with his HTLV-I seropositive wife as the donor. He developed HAM eight months after renal transplantation. Both cases showed neurological improvements after the immunomodulating therapies. We tried to shed some light on the understanding of immunological mechanisms of transplantation-associated HAM, focusing on therapeutic strategies based on the immunopathogenesis of the condition.
- 29 September 2016
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2016, 1-4
Open AccessTwo Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation
In rare instances, recipients of organ transplants from human T-lymphotropic virus type I- (HTLV-I-) positive donors reportedly developed neurologic symptoms due to HTLV-I-associated myelopathy (HAM). We present herein two cases of HAM associated with renal transplantation from HTLV-I seropositive living-donors. The first patient was a 42-year-old woman with chronic renal failure for twelve years and seronegative for HTLV-I. She underwent renal transplantation with her HTLV-I seropositive mother as the donor, and she developed HAM three years after the transplantation. The second patient was a 65-year-old man who had been suffering from diabetic nephropathy. He was seronegative for HTLV-I and underwent renal transplantation one year previously, with his HTLV-I seropositive wife as the donor. He developed HAM eight months after renal transplantation. Both cases showed neurological improvements after the immunomodulating therapies. We tried to shed some light on the understanding of immunological mechanisms of transplantation-associated HAM, focusing on therapeutic strategies based on the immunopathogenesis of the condition.